Close
CDMO Safety Testing 2026
Novotech

IT & Data Management

Successful Customer Meet in Hyderabad Romaco in a strong position in India

A record-breaking 400 guests turned up at the Customer Meet to witness the official opening of the Romaco Sales & Service Centre in India. Romacoโ€™s new agent on the Indian subcontinent has offices in Mumbai and Hyderabad. This is...

Clinerion partners with 2 GL Outsourcing to bring patients and hospitals in Serbia and Bosnia and Herzegovina quicker access to next generation medical treatments

2 GL Outsourcing is a dynamic and highly flexible pharmaceutical and clinical contract research and outsourcing organization providing a full range of professional services for the setting up and support of clinical research and development projects. 2 GLโ€™s scope of...

Libtayo cemiplima approved for Advanced Cutaneous Squamous Cell Carcinoma in the European Union

Regeneron Pharmaceuticals, Inc. and Sanofiย  announced that the EC has granted conditional marketing authorization for Libtayo for the treatment of adults with metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) who are not candidates for curative surgery or...

Cobra Biologics, Symbiosis complete 4.8M viral vector supply chain collaboration

Cobra Biologics, an international contract development and manufacturing organisation (CDMO) focused on viral vector drug substance production, and Symbiosis Pharmaceutical Services (Symbiosis), a contract manufacturing organisation (CMO) specialising in the sterile manufacture of injectable viral vector drug products, announced...

The Medison network of clinics Tbilisi Georgia joins Clinerions Patient Network Explorer platform bringing their patients accelerated access to next generation treatments and therapies

The Medison network of clinics specializes in outpatient and dental services for all social strata, focusing on patient health care, disease prevention, and timely and correct diagnosis. The four clinics in Tbilisi, Georgia, provide medical care to over 6,000...

Exploristics announces upcoming launch of KerusCloud 2.0 at BIO 2019

Data analysis and clinical trial software specialist, Exploristics, is pleased to announce at BIO 2019 plans to launch an updated version of its cloud-based data analytics platform for clinical trial design, KerusCloud 2.0, by the end of the summer....

Why AI in Drug Discovery has Yet to Live Up to its Promise!

Being a life sciences researcher today involves being inundated with data from every direction. Every day, new studies are published, conferences held, and experiments conducted. Despite rumours the age of the โ€˜blockbusterโ€™ drug might be over, weโ€™re currently seeing record...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป